Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
  • Click here - to use the wp menu builder
Search
Home Biotech News

Biotech News

  • 2020 Watch List
  • 2021 Watch List
  • 2022 Watch List
  • 2023 Watch List
  • 2024 Watch List
  • 2025 Watch List
  • 2026 Biotech 12 Pack
  • 2026 Vaccine Stock Watch List
  • Cannabis
  • Clinic
  • CoronaVirus
  • Diabetes
  • Exsosomes
  • Glutathione
  • Incubator
  • Infections
  • Mpox
  • Nipah
  • Opioids
  • Stem Cells
  • Telehealth
  • Vaccines

    GeoVax (GOVX) Monkeypox (MPOX) PowerPoint.

    Editor / Curator - May 26, 2026

    GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!

    Editor / Curator - May 21, 2026

    Cabaletta (CABA) Surges 44% on Massive Volume Spike.

    Editor / Curator - May 6, 2026

    GeoVax (GOVX) Surges 51% on Massive Volume Spike.

    Editor / Curator - May 4, 2026

    Paving Past Obstacles on the Path to US Biosecurity

    Editor / Curator - April 30, 2026

    GeoVax (GOVX) Reports 2025 Year-End Financial Results and Provides Business Update

    Editor / Curator - April 28, 2026

    Danger Will Robinson: the NIPAH Virus with a 40-75% Death Rate...

    Editor / Curator - April 28, 2026

    Report: AI Powered Review on GeoVax (GOVX) $1.15

    Editor / Curator - April 24, 2026

    Biotech Stock Review is Back! Timing Feels Perfect. 4 Companies Added...

    Editor / Curator - April 23, 2026

    Replimune (REPL). $269 Million in Cash and a $178 Million Market...

    Editor / Curator - April 22, 2026

    GeoVax (GOVX) Reports Both Favorable Safety and “It’s Working” News...

    Editor / Curator - December 8, 2025
    DAVID DODD GEOVAX

    Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture

    Editor / Curator - November 30, 2025

    Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical...

    Editor / Curator - November 22, 2025
    123...57Page 1 of 57
    ABOUT US
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: roland@institutionalanalyst.com
    © Managed by Revelers.IO Media Group Inc.